Literature DB >> 23188220

α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.

Yun-Hsuan Lee1, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Cheng-Yuan Hsia, Teh-Ia Huo.   

Abstract

BACKGROUND/AIMS: Serum α-fetoprotein (AFP) and total tumor volume (TTV) are important factors linked with post-operative tumor recurrence in hepatocellular carcinoma (HCC) patients. We investigated the role of a new prognostic marker, AFP-to-TTV ratio, in predicting HCC recurrence.
METHODS: A total of 655 HCC patients undergoing resection were analyzed.
RESULTS: In the multivariate logistic model, serum AFP level [odds ratio (OR) 32.459, p = 0.012] and TTV (OR 0.006, p = 0.01) were independently associated with a higher AFT/TTV ratio. The 1-, 3-, and 5-year tumor recurrence rates were 29 %, 55 %, and 68 %, respectively. In the Cox proportional hazards model, alcoholism (hazard ratio [HR], 1.354, p = 0.028), international normalized ratio of prothrombin time ≥1.01 (HR, 1.349, p < 0.001), multiple nodules (HR, 1.381, p = 0.004), main tumor diameter ≥4 cm (HR, 1.535, p = 0.001), macrovascular invasion (HR, 1.362, p = 0.016), and AFP/TTV ratio ≥1.5 (HR, 1.49, p < 0.001) were independently associated with tumor recurrence. In subgroup analysis, a higher AFP/TTV ratio was significantly associated with tumor recurrence in patients characterized by macrovascular invasion, TTV ≥ 40 cm(3), or main tumor diameter ≥4cm (all p = 0.001).
CONCLUSION: The AFP/TTV ratio, a newly proposed marker for predicting post-operative tumor recurrence in HCC, is a feasible surrogate and may be useful in selecting super-high-risk patients for tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188220     DOI: 10.1007/s11605-012-2081-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

1.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.

Authors:  Elizabeth Brandon-Warner; Tracy L Walling; Laura W Schrum; Iain H McKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

Review 3.  Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.

Authors:  A R Hakeem; R S Young; G Marangoni; J P A Lodge; K R Prasad
Journal:  Aliment Pharmacol Ther       Date:  2012-03-20       Impact factor: 8.171

4.  Influences of tobacco and alcohol use on hepatocellular carcinoma survival.

Authors:  Wei-Liang Shih; Hung-Chuen Chang; Yun-Fan Liaw; Shi-Ming Lin; Shou-Dong Lee; Pei-Jer Chen; Chun-Jen Liu; Chih-Lin Lin; Ming-Whei Yu
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

5.  Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.

Authors:  Y H Huang; J C Wu; W Y Lui; G Y Chau; S H Tsay; J H Chiang; K L King; T I Huo; F Y Chang; S D Lee
Journal:  World J Surg       Date:  2000-05       Impact factor: 3.352

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.

Authors:  Patrick P McHugh; Jeffrey Gilbert; Santiago Vera; Alvaro Koch; Dinesh Ranjan; Roberto Gedaly
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

8.  Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma.

Authors:  Yun-Hsuan Lee; Chia-Yang Hsu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Chien-Wei Su; Yi-You Chiou; Han-Chieh Lin; Teh-Ia Huo; Shou-Dong Lee
Journal:  Hepatol Int       Date:  2012-05-17       Impact factor: 6.047

9.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Authors:  Jian-Min Yuan; Sugantha Govindarajan; Kazuko Arakawa; Mimi C Yu
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

10.  Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.

Authors:  Christian Toso; Sonal Asthana; David L Bigam; A M James Shapiro; Norman M Kneteman
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more
  12 in total

1.  The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome.

Authors:  Marc-Antoine Allard; Antonio Sa Cunha; Aldrick Ruiz; Eric Vibert; Mylène Sebagh; Denis Castaing; René Adam
Journal:  J Gastrointest Surg       Date:  2014-01-09       Impact factor: 3.452

Review 2.  Resection for hepatocellular carcinoma.

Authors:  Hariharan Ramesh
Journal:  J Clin Exp Hepatol       Date:  2014-08-27

3.  A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study.

Authors:  Wei Qin; Li Wang; Beiyuan Hu; Shusheng Leng; Huan Tian; Huanxian Luo; Jia Yao; Xiaolong Chen; Chao Wu; Guihua Chen; Yang Yang
Journal:  J Gastrointest Surg       Date:  2018-11-16       Impact factor: 3.452

4.  Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.

Authors:  Mu-Xing Li; Hong Zhao; Xin-Yu Bi; Zhi-Yu Li; Zhen Huang; Yue Han; Jian-Guo Zhou; Jian-Jun Zhao; Ye-Fan Zhang; Wen-Qiang Wei; Dong-Bin Zhao; Jian-Qiang Cai
Journal:  Tumour Biol       Date:  2016-01-15

Review 5.  Screening for hepatocellular carcinoma: What is missing?

Authors:  Neil J Mehta; Aygul Dogan Celik; Marion G Peters
Journal:  Hepatol Commun       Date:  2016-12-19

6.  Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.

Authors:  Hazem M Zakaria; Anwar Mohamed; Hazem Omar; Nahla K Gaballa
Journal:  Ann Med Surg (Lond)       Date:  2020-05-04

7.  Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.

Authors:  Hazem M Zakaria; Mahmoud Macshut; Nahla K Gaballa; Ahmed E Sherif; Mohammed E Abdel-Samea; Mohamed Abdel-Samiee; Ibrahim Marwan; Taha Yassein
Journal:  Ann Med Surg (Lond)       Date:  2020-04-07

8.  The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.

Authors:  Tao Jiang; Xiao-Shi Zhang; Fei Pan; Shao-Cheng Lyu; Jing Wang; Meng-Xiu Huang; Qiang He; Ren Lang
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

9.  Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.

Authors:  Chia-Yang Hsu; Yun-Hsuan Lee; Po-Hong Liu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Han-Chieh Lin; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

10.  Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.

Authors:  Chia-Yang Hsu; Po-Hong Liu; Shu-Yein Ho; Cheng-Yuan Hsia; Praneeth Kudaravalli; Yun-Hsuan Lee; Yi-You Chiou; Ya-Ju Tsai; Yi-Hsiang Huang; Teh-Ia Huo
Journal:  BMC Cancer       Date:  2018-03-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.